Skip to main content
. 2022 Jan 27;2022:1849969. doi: 10.1155/2022/1849969

Table 5.

Pearson's correlation analysis of doxorubicin dose and parameters in all patients.

Group TAPSE (mm) RVFAC (%) LVEF (%) RVGCS (%)
r −0.286 −0.239 −0.260 −0.569
P 0.078 0.143 0.110 <0.001

Group RVGLS (%) RVGRS (%) LVGLS (%) LVGRS (%)

r −0.636 −0.433 −0.530 −0.303
P <0.001 0.006 <0.001 0.061